[go: up one dir, main page]

ATE438388T1 - Arzneimittel zur gesteuerten freisetzung von paracetamol - Google Patents

Arzneimittel zur gesteuerten freisetzung von paracetamol

Info

Publication number
ATE438388T1
ATE438388T1 AT01933832T AT01933832T ATE438388T1 AT E438388 T1 ATE438388 T1 AT E438388T1 AT 01933832 T AT01933832 T AT 01933832T AT 01933832 T AT01933832 T AT 01933832T AT E438388 T1 ATE438388 T1 AT E438388T1
Authority
AT
Austria
Prior art keywords
paracetamol
controlled release
medicinal products
release phase
unique
Prior art date
Application number
AT01933832T
Other languages
English (en)
Inventor
Shing Yue Chan
Timothy James Grattan
Bounkhiene Sengmanee
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9890126&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE438388(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of ATE438388T1 publication Critical patent/ATE438388T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Confectionery (AREA)
AT01933832T 2000-04-19 2001-04-12 Arzneimittel zur gesteuerten freisetzung von paracetamol ATE438388T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0009522.4A GB0009522D0 (en) 2000-04-19 2000-04-19 Composition
PCT/EP2001/004302 WO2001080834A1 (en) 2000-04-19 2001-04-12 Composition

Publications (1)

Publication Number Publication Date
ATE438388T1 true ATE438388T1 (de) 2009-08-15

Family

ID=9890126

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01933832T ATE438388T1 (de) 2000-04-19 2001-04-12 Arzneimittel zur gesteuerten freisetzung von paracetamol

Country Status (25)

Country Link
US (2) US7943170B2 (de)
EP (1) EP1274402B1 (de)
JP (1) JP2003531165A (de)
KR (1) KR100845660B1 (de)
CN (1) CN100335046C (de)
AT (1) ATE438388T1 (de)
AU (2) AU2001260212C1 (de)
BR (1) BR0110129A (de)
CA (1) CA2406373C (de)
CO (1) CO5280073A1 (de)
CY (1) CY1109483T1 (de)
CZ (1) CZ303275B6 (de)
DE (1) DE60139462D1 (de)
DK (1) DK1274402T3 (de)
EA (1) EA006103B1 (de)
ES (1) ES2329971T3 (de)
GB (1) GB0009522D0 (de)
HK (1) HK1053601A1 (de)
HU (1) HU230033B1 (de)
MX (1) MXPA02010347A (de)
NZ (1) NZ521799A (de)
TW (1) TWI282286B (de)
UA (1) UA76417C2 (de)
WO (1) WO2001080834A1 (de)
ZA (1) ZA200208084B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009522D0 (en) * 2000-04-19 2000-06-07 Smithkline Beecham Plc Composition
TWI319713B (en) 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US8487002B2 (en) 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
CN100348974C (zh) * 2003-09-30 2007-11-14 北京东方凯恩医药科技有限公司 一种药物组合物的检测方法
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions
BRPI0615860B8 (pt) 2005-09-09 2021-05-25 Labopharm Barbados Ltd composição farmacêutica de liberação prolongada monolítica sólida
US20080057122A1 (en) * 2006-08-31 2008-03-06 Aaipharma Inc. Acetaminophen pharmaceutical compositions
US8895066B2 (en) * 2007-10-16 2014-11-25 Paladin Labs Inc. Bilayer composition for the sustained release of acetaminophen and tramadol
BRPI0821732A2 (pt) 2007-12-17 2015-06-16 Labopharm Inc Formulações de liberação controlada , forma de dosagem sólida, e, uso da formulação de liberação controlada
US9226907B2 (en) 2008-02-01 2016-01-05 Abbvie Inc. Extended release hydrocodone acetaminophen and related methods and uses thereof
US8372432B2 (en) 2008-03-11 2013-02-12 Depomed, Inc. Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
EP2262484B1 (de) * 2008-03-11 2013-01-23 Depomed, Inc. Gastroretentive darreichungsformen mit verzögerter freisetzung mit komibinationen aus einem nichtopioiden analgetikum und einem opioiden analgetikum
WO2010069050A1 (en) 2008-12-16 2010-06-24 Labopharm Inc. Misuse preventative, controlled release formulation
PL2395840T3 (pl) * 2009-02-13 2020-09-07 Romark Laboratories, L.C. Preparaty farmaceutyczne nitazoksanidu o kontrolowanym uwalnianiu
US20110052685A1 (en) * 2009-08-31 2011-03-03 Depomed, Inc. Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen
US9198861B2 (en) 2009-12-22 2015-12-01 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
US8597681B2 (en) 2009-12-22 2013-12-03 Mallinckrodt Llc Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
AP3878A (en) * 2011-05-06 2016-10-31 Glaxosmithkline Llc Sustained release paracetamol formulations
US8741885B1 (en) 2011-05-17 2014-06-03 Mallinckrodt Llc Gastric retentive extended release pharmaceutical compositions
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
US8658631B1 (en) 2011-05-17 2014-02-25 Mallinckrodt Llc Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
US20140206740A1 (en) * 2011-07-30 2014-07-24 Neurovance, Inc. Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters
CA2888883A1 (en) * 2012-10-18 2014-04-24 Abbvie Inc. Formulations of pyrimidinedione derivative compounds
WO2016042570A1 (en) * 2014-09-16 2016-03-24 Suresh Pareek Extended release formulation of acetaminophen
CA3016852C (en) * 2016-03-09 2021-03-23 Nls-1 Pharma Ag A mazindol ir/sr multilayer tablet and its use for the treatment of attention deficit/hyperactivity disorder (adhd)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2058562B (en) * 1979-09-14 1983-11-30 Beecham Group Ltd Pharmaceutical compositions containing paracetamol and ascorbic acid
US4786503A (en) 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4820522A (en) * 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
EP0418596A3 (en) 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
US5900425A (en) 1995-05-02 1999-05-04 Bayer Aktiengesellschaft Pharmaceutical preparations having controlled release of active compound and processes for their preparation
US5773031A (en) 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
BE1011045A3 (fr) 1997-03-14 1999-04-06 Ucb Sa Compositions pharmaceutiques pour la liberation controlee de substances actives.
FR2766708B1 (fr) 1997-07-30 2000-05-05 Galenix Dev Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellullose a titre d'agents desintegrants, et procede d'obtention
US5945123A (en) 1998-04-02 1999-08-31 K-V Pharmaceutical Company Maximizing effectiveness of substances used to improve health and well being
US6254891B1 (en) 1998-09-03 2001-07-03 Ascent Pediatrics, Inc. Extended release acetaminophen
US6126967A (en) * 1998-09-03 2000-10-03 Ascent Pediatrics Extended release acetaminophen particles
GB0009522D0 (en) * 2000-04-19 2000-06-07 Smithkline Beecham Plc Composition
US7897172B2 (en) 2004-05-18 2011-03-01 L. Perrigo Company Tablets exhibiting reduced drug release variability

Also Published As

Publication number Publication date
BR0110129A (pt) 2002-12-31
CZ303275B6 (cs) 2012-07-11
US20040202716A1 (en) 2004-10-14
AU2001260212B2 (en) 2006-09-21
CY1109483T1 (el) 2014-08-13
HUP0300698A3 (en) 2004-09-28
GB0009522D0 (en) 2000-06-07
CO5280073A1 (es) 2003-05-30
CN1426298A (zh) 2003-06-25
NZ521799A (en) 2004-12-24
KR20030009440A (ko) 2003-01-29
HK1053601A1 (en) 2003-10-31
MXPA02010347A (es) 2003-04-25
EP1274402B1 (de) 2009-08-05
DE60139462D1 (de) 2009-09-17
EP1274402A1 (de) 2003-01-15
CN100335046C (zh) 2007-09-05
DK1274402T3 (da) 2009-11-16
KR100845660B1 (ko) 2008-07-10
WO2001080834A1 (en) 2001-11-01
PL358123A1 (en) 2004-08-09
HU230033B1 (hu) 2015-05-28
UA76417C2 (en) 2006-08-15
US20110177168A1 (en) 2011-07-21
EA200200954A1 (ru) 2003-04-24
CA2406373C (en) 2010-06-29
US7943170B2 (en) 2011-05-17
JP2003531165A (ja) 2003-10-21
AU6021201A (en) 2001-11-07
HUP0300698A2 (hu) 2003-07-28
CZ20023470A3 (cs) 2003-03-12
ZA200208084B (en) 2003-10-08
EA006103B1 (ru) 2005-08-25
AU2001260212C1 (en) 2020-07-16
CA2406373A1 (en) 2001-11-01
ES2329971T3 (es) 2009-12-03
TWI282286B (en) 2007-06-11

Similar Documents

Publication Publication Date Title
ATE438388T1 (de) Arzneimittel zur gesteuerten freisetzung von paracetamol
DE60126321D1 (de) Gelsystem zur ocularen verabreichung von arzneimitteln
DE60235719D1 (de) Frauenhygieneartikel zur verabreichung von arzneimittel
EP1187602A4 (de) Injizierbare pharmazeutische zusammensetzung mit verzögerter freisetzung und verfahren zu deren herstellung
CY1105225T1 (el) Παραγωγα 5-β-σαπωγενινης και ψευδοσαπωγενινης και η χρηση τους στην αντιμετωπιση ανοιας
DK1341414T3 (da) Marint actinomycet-taxon til opdagelse af medikamenter og fermenteringsprodukter
ATE406889T1 (de) Arzneimittel zur gesteuerten freisetzung eines insulin sensibilisators und metformin
AU2003288126A1 (en) Anthranilic acid amides and the derivatives thereof as cosmetic and pharmaceutical agents
WO2004030611A3 (en) Non-nucleoside reverse transcriptase inhibitors
DE60131760D1 (de) Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform
CY1110906T1 (el) Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
PL367883A1 (en) Pharmaceutical formulation for the efficient administration of apomorphine, 6ar-(-)-n-propyl-norapomorphine and their derivatives and pro-drugs thereof
GB0017060D0 (en) Production, stabilisation and use of reduced forms of pharmaceutical compounds
AU2003223930A1 (en) Pharmaceutical use of boronic acids and esters thereof
AU777185C (en) Pharmaceutical form of administration for peptides, methods for its production and use
ATE295174T1 (de) Arzneimittel zur behandlung von bluthochdruck
ATE281155T1 (de) Medikamentöse verabreichung von proteinen aus polymergemischen
ATE262893T1 (de) Darreichungsformen zur behandlung von oralen mykosen
ITMI20001827A0 (it) Medicamento antinfiammatorio
SE0001916D0 (sv) Novel formulation
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
ITMI20020872A1 (it) Derivati dell'iperforina loro uso e formulazioni che li contengono
ATE331509T1 (de) Zusammensetzung die paracetamol und niflumic säure enthält
DE60008415D1 (de) Zusammensetzung die mindestens ein stickstoffmonoxid-synthase inhibitor und mindestens ein phospholipase a2 inhibitor enthält zur herstellung eines medikamentes
DE60218683D1 (de) Pharmazeutische zusammensetzung für die nasale verabreichung von östradiol und norethisteron

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties